IN-vivo Ventures helps inventors and universities transform new technologies into exciting start-up ventures. Serving as the Founding Entrepreneur\CEO, In-vivo Ventures forms a new company around a technology and surrounds it with a management team experienced in raising capital and starting successful ventures. We have defined processes that yield solid business strategies and plans, fundable intellectual property positions, and corporate structures. Most importantly, our processes yield a funding structure that provides an inventor with a more equitable stake in the company, and gives investors and intellectual property licensors higher returns. Indiana-based venture capital firm formed in 2003. Its mission is to cultivate and create economic value from the most promising platform technologies emerging from research universities and inventors by seeding each of several new companies with capital, qualified and professional management, and by streamlining the process of licensing and commercializing those technologies. As the Founding Entrepreneur/Management Team, In-vivo Ventures provides a fledgling company with management experienced in both raising capital and starting successful ventures. In-vivo has defined processes that yield solid business strategies, strong corporate structures, and fundable intellectual property. Most importantly, it yields funding structures that provide an inventor with a more equitable stake in the company, and it provides investors and intellectual property licensors with higher returns. The In-vivo model has proven successful and has the support of some of the finest Midwest research institutions. To date In-vivo has formed Copient Technologies, Inc. (www.copienttech.com), Nuron, LLC (acquired by Intel), Arxan Technologies, Inc. (www.arxan.com), Quadraspec, Inc. (www.quadraspec.com), and Kylin Therapeutics, Inc. (www.kylintherapeutics.com). You may visit In-vivo’s web site at www.in-vivoventures.com.